UNH: financial statements from SEC — TradeAlmanac

UNH

UnitedHealth Group Incorporated Common Stock (DE): financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	111.72bn	113.16bn	111.62bn	109.58bn	100.82bn	98.86bn
Cost of revenue	12.82bn	12.57bn	13.02bn	12.39bn	11.83bn	11.34bn
Selling, general and administrative	15.39bn	15.22bn	13.78bn	13.59bn	13.28bn	13.16bn
Operating expenses	102.73bn	108.85bn	106.47bn	100.46bn	92.11bn	90.98bn
Operating income	8.99bn	4.32bn	5.15bn	9.12bn	8.71bn	7.88bn
Interest expense	955m	1.00bn	1.03bn	998m	1.07bn	985m
Pre-tax income	7.96bn	3.23bn	4.08bn	8.11bn	7.61bn	5.67bn
Income tax	1.48bn	686m	510m	1.63bn	1.36bn	1.24bn
Net income	6.28bn	2.35bn	3.41bn	6.29bn	6.06bn	4.22bn
Earnings per share	6.92	2.59	3.76	6.90	6.56	4.58
Earnings per share, diluted	6.90	2.59	3.74	6.85	6.51	4.54
Weighted average shares	908m	906m	907m	912m	923m	921m
Weighted average shares, diluted	910m	908m	910m	918m	930m	928m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	28.00bn	24.37bn	27.21bn	28.60bn	30.72bn	25.31bn	32.40bn	26.29bn
Short-term investments	3.23bn	3.76bn

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	8.91bn	—	—	5.46bn	—	—
Depreciation and amortisation	1.03bn	1.10bn	1.08bn	1.06bn

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)